- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/85 - Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Patent holdings for IPC class C12N 15/85
Total number of patents in this class: 10622
10-year publication summary
584
|
630
|
764
|
1013
|
1012
|
885
|
1001
|
1024
|
1030
|
423
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Regeneron Pharmaceuticals, Inc. | 4211 |
370 |
The Regents of the University of California | 19784 |
214 |
Massachusetts Institute of Technology | 9984 |
154 |
The Trustees of the University of Pennsylvania | 4295 |
142 |
President and Fellows of Harvard College | 5935 |
132 |
The Broad Institute, Inc. | 1772 |
94 |
The Board of Trustees of the Leland Stanford Junior University | 6329 |
92 |
Sangamo Therapeutics, Inc. | 415 |
75 |
Kymab Limited | 250 |
63 |
The General Hospital Corporation | 4700 |
58 |
The Johns Hopkins University | 5628 |
57 |
Biocytogen Pharmaceuticals (Beijing) Co., Ltd | 172 |
57 |
University of Massachusetts | 2214 |
56 |
Duke University | 3056 |
54 |
Novartis AG | 10963 |
52 |
Modernatx, Inc. | 1258 |
52 |
Board of Regents, The University of Texas System | 5738 |
48 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2832 |
47 |
Yale University | 2350 |
45 |
Inscripta, Inc., FORMERLY Muse Biotechnology, Inc. | 309 |
41 |
Other owners | 8719 |